Pricing Log in Create free account

Black Diamond Therapeutics, Inc. (BDTX) vs Unicycive Therapeutics, Inc. (UNCY)

Black Diamond Therapeutics, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Unicycive Therapeutics, Inc. are of similar size ($100.0M and $100.0M). Across the 8 metrics below, Black Diamond Therapeutics, Inc. leads on 7 and Unicycive Therapeutics, Inc. on 1.

Valuation

Metric BDTX UNCY Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.03 1.70 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.23 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (43.60%) (52.08%) (33.15%)
Free cash flow yield (33.25%) (30.79%) (25.50%)

Profitability

Metric BDTX UNCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) (101.07%) (56.36%)
Return on assets (29.21%) (69.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDTX UNCY Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 130.71% 70.18% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 3.81 4.72
Net debt to EBITDA (10.01) 1.43 0.96

Dividend

Metric BDTX UNCY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDTX UNCY Biotechnology median
Market cap 99.97m 100.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack